White IN - Search Results

1

Species differences in the covalent binding of [14C]tamoxifen to liver microsomes and the forms of cytochrome P450 involved.

White IN, De Matteis F, Gibbs AH, Lim CK, Wolf CR, Henderson C, Smith LL. White IN, et al. Biochem Pharmacol. 1995 Apr 18;49(8):1035-42. doi: 10.1016/0006-2952(95)98498-x. Biochem Pharmacol. 1995. PMID: 7748182

2

Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA.

Boocock DJ, Brown K, Gibbs AH, Sanchez E, Turteltaub KW, White IN. Boocock DJ, et al. Among authors: white in. Carcinogenesis. 2002 Nov;23(11):1897-901. doi: 10.1093/carcin/23.11.1897. Carcinogenesis. 2002. PMID: 12419838

3

DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation.

Carthew P, Rich KJ, Martin EA, De Matteis F, Lim CK, Manson MM, Festing MF, White IN, Smith LL. Carthew P, et al. Among authors: white in. Carcinogenesis. 1995 Jun;16(6):1299-304. doi: 10.1093/carcin/16.6.1299. Carcinogenesis. 1995. PMID: 7788846

4

A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes.

Lim CK, Yuan ZX, Lamb JH, White IN, De Matteis F, Smith LL. Lim CK, et al. Among authors: white in. Carcinogenesis. 1994 Apr;15(4):589-93. doi: 10.1093/carcin/15.4.589. Carcinogenesis. 1994. PMID: 8149466

5

Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s.

Styles JA, Davies A, Lim CK, De Matteis F, Stanley LA, White IN, Yuan ZX, Smith LL. Styles JA, et al. Among authors: white in. Carcinogenesis. 1994 Jan;15(1):5-9. doi: 10.1093/carcin/15.1.5. Carcinogenesis. 1994. PMID: 8293548

6

Metabolic activation of halothane to neoantigens in C57Bl/10 mice: immunochemical studies.

Heijink E, De Matteis F, Gibbs AH, Davies A, White IN. Heijink E, et al. Among authors: white in. Eur J Pharmacol. 1993 Jun 1;248(1):15-25. doi: 10.1016/0926-6917(93)90020-q. Eur J Pharmacol. 1993. PMID: 8339751

7

Induction of CYP2B1 and 3A1, and associated monoxygenase activities by tamoxifen and certain analogues in the livers of female rats and mice.

White IN, Davies A, Smith LL, Dawson S, De Matteis F. White IN, et al. Biochem Pharmacol. 1993 Jan 7;45(1):21-30. doi: 10.1016/0006-2952(93)90372-4. Biochem Pharmacol. 1993. PMID: 8424814

8

Chemoprevention of breast cancer by tamoxifen: risks and opportunities.

Smith LL, White IN. Smith LL, et al. Among authors: white in. Toxicol Lett. 1995 Dec;82-83:181-6. doi: 10.1016/0378-4274(95)03476-5. Toxicol Lett. 1995. PMID: 8597049 Review.

9

Comparisons of the binding of [14C]radiolabelled tamoxifen or toremifene to rat DNA using accelerator mass spectrometry.

White IN, Martin EA, Mauthe RJ, Vogel JS, Turteltaub KW, Smith LL. White IN, et al. Chem Biol Interact. 1997 Sep 12;106(2):149-60. doi: 10.1016/s0009-2797(97)00063-x. Chem Biol Interact. 1997. PMID: 9366900

10

Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells.

White IN, de Matteis F, Davies A, Smith LL, Crofton-Sleigh C, Venitt S, Hewer A, Phillips DH. White IN, et al. Carcinogenesis. 1992 Dec;13(12):2197-203. doi: 10.1093/carcin/13.12.2197. Carcinogenesis. 1992. PMID: 1473224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters